S&P 500   3,103.54 (-0.16%)
DOW   27,766.29 (-0.20%)
QQQ   201.70 (-0.22%)
FB   197.93 (+0.21%)
MSFT   149.48 (-0.09%)
GOOGL   1,300.14 (-0.13%)
AMZN   1,734.71 (-0.62%)
CGC   20.29 (+15.02%)
NVDA   210.18 (-0.47%)
MU   45.55 (-0.04%)
BABA   184.86 (+1.38%)
GE   11.53 (+1.23%)
T   37.60 (+1.13%)
AMD   39.52 (-3.56%)
ACB   3.12 (+18.18%)
F   8.71 (-0.23%)
PRI   130.45 (-0.81%)
NFLX   311.69 (+2.14%)
BAC   32.84 (+0.46%)
GILD   65.73 (+1.31%)
DIS   146.90 (-0.02%)
S&P 500   3,103.54 (-0.16%)
DOW   27,766.29 (-0.20%)
QQQ   201.70 (-0.22%)
FB   197.93 (+0.21%)
MSFT   149.48 (-0.09%)
GOOGL   1,300.14 (-0.13%)
AMZN   1,734.71 (-0.62%)
CGC   20.29 (+15.02%)
NVDA   210.18 (-0.47%)
MU   45.55 (-0.04%)
BABA   184.86 (+1.38%)
GE   11.53 (+1.23%)
T   37.60 (+1.13%)
AMD   39.52 (-3.56%)
ACB   3.12 (+18.18%)
F   8.71 (-0.23%)
PRI   130.45 (-0.81%)
NFLX   311.69 (+2.14%)
BAC   32.84 (+0.46%)
GILD   65.73 (+1.31%)
DIS   146.90 (-0.02%)
S&P 500   3,103.54 (-0.16%)
DOW   27,766.29 (-0.20%)
QQQ   201.70 (-0.22%)
FB   197.93 (+0.21%)
MSFT   149.48 (-0.09%)
GOOGL   1,300.14 (-0.13%)
AMZN   1,734.71 (-0.62%)
CGC   20.29 (+15.02%)
NVDA   210.18 (-0.47%)
MU   45.55 (-0.04%)
BABA   184.86 (+1.38%)
GE   11.53 (+1.23%)
T   37.60 (+1.13%)
AMD   39.52 (-3.56%)
ACB   3.12 (+18.18%)
F   8.71 (-0.23%)
PRI   130.45 (-0.81%)
NFLX   311.69 (+2.14%)
BAC   32.84 (+0.46%)
GILD   65.73 (+1.31%)
DIS   146.90 (-0.02%)
S&P 500   3,103.54 (-0.16%)
DOW   27,766.29 (-0.20%)
QQQ   201.70 (-0.22%)
FB   197.93 (+0.21%)
MSFT   149.48 (-0.09%)
GOOGL   1,300.14 (-0.13%)
AMZN   1,734.71 (-0.62%)
CGC   20.29 (+15.02%)
NVDA   210.18 (-0.47%)
MU   45.55 (-0.04%)
BABA   184.86 (+1.38%)
GE   11.53 (+1.23%)
T   37.60 (+1.13%)
AMD   39.52 (-3.56%)
ACB   3.12 (+18.18%)
F   8.71 (-0.23%)
PRI   130.45 (-0.81%)
NFLX   311.69 (+2.14%)
BAC   32.84 (+0.46%)
GILD   65.73 (+1.31%)
DIS   146.90 (-0.02%)
Log in

Medmen Enterprises Stock Price, Forecast & Analysis (CNSX:MMEN)

Today's Range N/A
50-Day Range
$2.33
MA: $2.84
$3.53
52-Week Range N/A
Volume458,881 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
MedMen Enterprises Inc., together with its subsidiaries, operates as a cannabis company in the United States. The company cultivates, produces, and distributes, and retails recreational and medicinal cannabis. As of November 1, 2018, it had licenses for 69 retail stores; and 17 cultivation and production facilities across 12 states. The company is headquartered in Culver City, California.

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone424-341-4969

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive MMEN News and Ratings via Email

Sign-up to receive the latest news and ratings for MMEN and its competitors with MarketBeat's FREE daily newsletter.


Medmen Enterprises (CNSX:MMEN) Frequently Asked Questions

What is Medmen Enterprises' stock symbol?

Medmen Enterprises trades on the CNSX under the ticker symbol "MMEN."

Has Medmen Enterprises been receiving favorable news coverage?

Media coverage about MMEN stock has been trending somewhat negative on Thursday, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Medmen Enterprises earned a news sentiment score of -1.3 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for Medmen Enterprises.

Who are some of Medmen Enterprises' key competitors?

What other stocks do shareholders of Medmen Enterprises own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medmen Enterprises investors own include Aurora Cannabis (ACB), OrganiGram (OGI), Green Organic Dutchman (TGOD), Aurora Cannabis (ACB), Canopy Growth (WEED), CannTrust (CTST), Canopy Growth (CGC), Curaleaf (CURLF), Medmen Enterprises (MMNFF) and Cronos Group (CRON).

Who are Medmen Enterprises' key executives?

Medmen Enterprises' management team includes the folowing people:
  • Mr. Adam Bierman, Co-Founder, CEO & Director (Age 38)
  • Mr. Andrew Modlin, Co-Founder, Pres & Director (Age 32)
  • Mr. Michael W. Kramer, Chief Financial Officer (Age 55)
  • Mr. James Miller, VP of Accounting (Age 59)
  • Mr. Ryan Lissack, Chief Technology Officer

How do I buy shares of Medmen Enterprises?

Shares of MMEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Medmen Enterprises' official website?

The official website for Medmen Enterprises is http://www.medmen.com/.

How can I contact Medmen Enterprises?

The company can be reached via phone at 424-341-4969.


MarketBeat Community Rating for Medmen Enterprises (CNSX MMEN)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  27 (Vote Outperform)
Underperform Votes:  15 (Vote Underperform)
Total Votes:  42
MarketBeat's community ratings are surveys of what our community members think about Medmen Enterprises and other stocks. Vote "Outperform" if you believe MMEN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MMEN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/21/2019 by MarketBeat.com Staff

Featured Article: What is the Quick Ratio?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel